$0.8400
0.1216.39%
In chiusura: Nov 20, 4:00 PM EST
$0.8100
-0.03-3.57%
Post-mercato: Nov 20, 7:58 PM EST

The average analyst price target for Aldeyra Therapeutics is $7, 764.2% above the current price. Of 3 analysts, 2 rate it Buy and 1 Hold. Targets range from $2 to $10. The latest change came on Mar 18, 2026, when HC Wainwright & Co. downgraded Aldeyra Therapeutics from Buy to Neutral and moved its price target from $10 to $2.
Price Target Range — 7 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months